Insulet Corp (PODD)

$331.83 +2.83 (0.86%)
Market Cap 23.16B
Revenue (ttm) 2.07B
Net Income (ttm) 418.30M
EPS (ttm) N/A
PE Ratio 78.01
Forward PE 72.05
Profit Margin 20.19%
Debt to Equity Ratio 0.96
Volume 493,000
Avg Vol 685,806
Day's Range N/A - N/A
Shares Out 70.39M
Stochastic %K 91%
Beta 1.35
Analysts Strong Sell
Price Target $355.18

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
jheerdink
jheerdink Aug. 26 at 11:25 PM
$MODD Production Milestone Further Positions Modular Medical for U.S. and EU Growth https://vistapglobal.com/production-milestone-further-positions-modular-medical-for-u-s-and-eu-growth-modd-lly-mdt-podd/ $LLY $PODD
0 · Reply
contangoz
contangoz Aug. 25 at 9:31 PM
$PODD new COO
0 · Reply
jheerdink
jheerdink Aug. 25 at 6:46 PM
$MODD Headed up Modular Medical has surged 8.33% to $0.78 on Monday. Check it out on Yahoo Finance https://finance.yahoo.com/quote/MODD?p=MODD $PODD
0 · Reply
Anecdotal
Anecdotal Aug. 25 at 2:27 PM
Y'all are missing it. Synergies. $PODD
0 · Reply
ZacksResearch
ZacksResearch Aug. 22 at 2:43 PM
$PODD's 77% rise in a year — what's driving the surge? 🚀 Insulet's Omnipod 5 expansion is growing its market presence, with launches across Europe and Australia, plus an impressive 122.2% increase in operating profit in the second quarter of 2025. The Zacks Rank #3 (Hold) status and a robust cash position of $1.12B bolster its growth story. Full potential and headwinds explored here 👉 https://www.zacks.com/stock/news/2741538/insulet-gains-772-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741538-body-9052&ADID=SYND_STOCKTWITS_TWEET_2_2741538_BODY_9052
0 · Reply
ZacksResearch
ZacksResearch Aug. 22 at 1:43 PM
$PODD up 77.2% in a year — can it retain momentum? 🚀 Omnipod 5 expansion, global launches, strong Q2 profits, and solid financial footing are powering the rally. Full breakdown here 👉 https://www.zacks.com/stock/news/2741538/insulet-gains-772-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741538-teaser-9050&ADID=SYND_STOCKTWITS_TWEET_2_2741538_TEASER_9050
0 · Reply
JarvisFlow
JarvisFlow Aug. 21 at 2:43 PM
Barclays updates rating for Insulet ( $PODD ) to Equal-Weight, target set at 266 → 300.
0 · Reply
JFDI
JFDI Aug. 20 at 9:12 PM
yeah, actually $PODD think fav set up. hope we get some follow thru on this sucker.
0 · Reply
JFDI
JFDI Aug. 20 at 7:47 PM
$PODD
1 · Reply
MaverikIT
MaverikIT Aug. 20 at 1:53 PM
$PODD +4 - they shook da treee$ after last ER
0 · Reply
Latest News on PODD
Insulet Elevates Eric Benjamin to Chief Operating Officer

Aug 25, 2025, 5:00 PM EDT - 1 day ago

Insulet Elevates Eric Benjamin to Chief Operating Officer

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

Aug 19, 2025, 1:20 PM EDT - 7 days ago

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

CSCO RKT IGV

Insulet to Participate in Upcoming Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 8 days ago

Insulet to Participate in Upcoming Investor Conferences

20 stocks in the S&P 500 that are high achievers this earnings season

Aug 15, 2025, 8:52 AM EDT - 12 days ago

20 stocks in the S&P 500 that are high achievers this earnings season

ANET APH COIN CTRA EQT EXE FICO

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Aug 13, 2025, 11:49 PM EDT - 13 days ago

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Aug 7, 2025, 1:08 PM EDT - 19 days ago

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 11:14 AM EDT - 20 days ago

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Aug 7, 2025, 8:39 AM EDT - 20 days ago

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

Aug 7, 2025, 7:00 AM EDT - 20 days ago

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

Jul 31, 2025, 9:52 AM EDT - 27 days ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY SYK

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

Jul 21, 2025, 10:27 AM EDT - 5 weeks ago

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

CMG COF DXCM FSLR INTU LLY MA

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Jul 8, 2025, 6:00 AM EDT - 7 weeks ago

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Jun 19, 2025, 6:00 AM EDT - 2 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

20 stocks bucking bad trends on Wall Street — what might be next for them?

Jun 10, 2025, 10:53 AM EDT - 2 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO BSX TRMB BAC C

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Jun 10, 2025, 8:30 AM EDT - 2 months ago

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

20 stocks of companies that have improved profit margins and are expected to grow quickly

Jun 9, 2025, 9:28 AM EDT - 2 months ago

20 stocks of companies that have improved profit margins and are expected to grow quickly

AMD AVGO CSGP DASH ENPH FICO FTNT

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 23, 2025, 6:01 AM EDT - 3 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Outlier Money Flows Lift Insulet

May 14, 2025, 7:20 AM EDT - 3 months ago

Outlier Money Flows Lift Insulet

Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025, 6:00 AM EDT - 3 months ago

Insulet Announces Publication of 2024 Sustainability Report

20 stocks of companies showing excellent earnings-season trends even as the economy cools

May 12, 2025, 11:18 AM EDT - 3 months ago

20 stocks of companies showing excellent earnings-season trends even as the economy cools

AMD APH CF CTRA DVN ENPH EQT

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

May 9, 2025, 6:31 PM EDT - 3 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

May 9, 2025, 12:31 PM EDT - 3 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

MNST TSLA

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

May 9, 2025, 11:05 AM EDT - 3 months ago

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

Insulet Is the Top S&P 500 Performer Today. Here's Why.

May 9, 2025, 10:11 AM EDT - 3 months ago

Insulet Is the Top S&P 500 Performer Today. Here's Why.

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:35 PM EDT - 3 months ago

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

Insulet beats quarterly profit estimates on insulin pump demand

May 8, 2025, 4:28 PM EDT - 3 months ago

Insulet beats quarterly profit estimates on insulin pump demand

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

May 8, 2025, 4:01 PM EDT - 3 months ago

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

Insulet Names New CEO, Expects to Top Revenue Projections

Apr 28, 2025, 10:26 AM EDT - 4 months ago

Insulet Names New CEO, Expects to Top Revenue Projections

Insulet Appoints Ashley McEvoy President and CEO

Apr 28, 2025, 6:00 AM EDT - 4 months ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 6:00 AM EDT - 5 months ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Mar 19, 2025, 4:01 PM EDT - 5 months ago

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Insulet Announces Pricing of Senior Notes Due 2033

Mar 18, 2025, 4:32 PM EDT - 5 months ago

Insulet Announces Pricing of Senior Notes Due 2033

Insulet Announces Proposed Financing Transactions

Mar 18, 2025, 7:35 AM EDT - 5 months ago

Insulet Announces Proposed Financing Transactions

Insulet Leans Bullish (Technical Analysis)

Mar 17, 2025, 11:53 PM EDT - 5 months ago

Insulet Leans Bullish (Technical Analysis)

Insulet to Host Investor Day on June 5, 2025

Mar 11, 2025, 6:00 AM EDT - 6 months ago

Insulet to Host Investor Day on June 5, 2025

Insulet Sales Keep Rising

Feb 26, 2025, 8:04 AM EST - 6 months ago

Insulet Sales Keep Rising

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Feb 21, 2025, 1:28 PM EST - 6 months ago

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 11:37 PM EST - 6 months ago

Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript

Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year

Feb 20, 2025, 4:01 PM EST - 6 months ago

Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Jan 13, 2025, 4:01 PM EST - 8 months ago

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Jan 10, 2025, 6:00 AM EST - 8 months ago

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Heavy Interest in Insulet's Insulin Delivery Device

Dec 27, 2024, 3:47 PM EST - 8 months ago

Heavy Interest in Insulet's Insulin Delivery Device

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

Dec 5, 2024, 11:05 AM EST - 9 months ago

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

Dec 4, 2024, 4:28 PM EST - 9 months ago

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines

Nov 20, 2024, 6:26 PM EST - 9 months ago

Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.

Nov 20, 2024, 8:30 AM EST - 10 months ago

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.

Insulet to Present at Upcoming Investor Conferences

Nov 15, 2024, 6:00 AM EST - 10 months ago

Insulet to Present at Upcoming Investor Conferences

Insulet CEO on earnings, GLP-1 and election impact

Nov 11, 2024, 4:59 PM EST - 10 months ago

Insulet CEO on earnings, GLP-1 and election impact

Buy, Sell, Or Hold Insulet (PODD) Stock?

Nov 11, 2024, 9:42 AM EST - 10 months ago

Buy, Sell, Or Hold Insulet (PODD) Stock?

Top 4 Health Care Stocks That May Plunge This Quarter

Nov 11, 2024, 6:18 AM EST - 10 months ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS NUVB QDEL

jheerdink
jheerdink Aug. 26 at 11:25 PM
$MODD Production Milestone Further Positions Modular Medical for U.S. and EU Growth https://vistapglobal.com/production-milestone-further-positions-modular-medical-for-u-s-and-eu-growth-modd-lly-mdt-podd/ $LLY $PODD
0 · Reply
contangoz
contangoz Aug. 25 at 9:31 PM
$PODD new COO
0 · Reply
jheerdink
jheerdink Aug. 25 at 6:46 PM
$MODD Headed up Modular Medical has surged 8.33% to $0.78 on Monday. Check it out on Yahoo Finance https://finance.yahoo.com/quote/MODD?p=MODD $PODD
0 · Reply
Anecdotal
Anecdotal Aug. 25 at 2:27 PM
Y'all are missing it. Synergies. $PODD
0 · Reply
ZacksResearch
ZacksResearch Aug. 22 at 2:43 PM
$PODD's 77% rise in a year — what's driving the surge? 🚀 Insulet's Omnipod 5 expansion is growing its market presence, with launches across Europe and Australia, plus an impressive 122.2% increase in operating profit in the second quarter of 2025. The Zacks Rank #3 (Hold) status and a robust cash position of $1.12B bolster its growth story. Full potential and headwinds explored here 👉 https://www.zacks.com/stock/news/2741538/insulet-gains-772-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741538-body-9052&ADID=SYND_STOCKTWITS_TWEET_2_2741538_BODY_9052
0 · Reply
ZacksResearch
ZacksResearch Aug. 22 at 1:43 PM
$PODD up 77.2% in a year — can it retain momentum? 🚀 Omnipod 5 expansion, global launches, strong Q2 profits, and solid financial footing are powering the rally. Full breakdown here 👉 https://www.zacks.com/stock/news/2741538/insulet-gains-772-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741538-teaser-9050&ADID=SYND_STOCKTWITS_TWEET_2_2741538_TEASER_9050
0 · Reply
JarvisFlow
JarvisFlow Aug. 21 at 2:43 PM
Barclays updates rating for Insulet ( $PODD ) to Equal-Weight, target set at 266 → 300.
0 · Reply
JFDI
JFDI Aug. 20 at 9:12 PM
yeah, actually $PODD think fav set up. hope we get some follow thru on this sucker.
0 · Reply
JFDI
JFDI Aug. 20 at 7:47 PM
$PODD
1 · Reply
MaverikIT
MaverikIT Aug. 20 at 1:53 PM
$PODD +4 - they shook da treee$ after last ER
0 · Reply
chopGhost88
chopGhost88 Aug. 18 at 4:20 PM
$PODD Insulet's Omnipod diabetes system grows steadily though competition increases.
0 · Reply
JFDI
JFDI Aug. 17 at 7:00 PM
$PODD
0 · Reply
ivanhoff
ivanhoff Aug. 14 at 5:36 PM
Range contraction in $PODD. Also triple digit earnings growth.
0 · Reply
ZacksResearch
ZacksResearch Aug. 12 at 1:37 PM
$PODD smashes Q2 expectations with 112.7% EPS growth! 🚀 💰 EPS of $1.17 beat the Zacks Consensus Estimate by 25.81% 📈 Revenues jumped 33% year over year, surpassing estimates by 5.46% 📊 Raised 2025 revenue guidance to 24%-27% growth at CER Discover what makes PODD a standout performer this quarter 👉 https://www.zacks.com/stock/news/2701834/insulet-q2-earnings-revenues-beat-estimates-stock-up-margins-rise?cid=sm-stocktwits-2-2701834-body-7337&ADID=SYND_STOCKTWITS_TWEET_2_2701834_BODY_7337
0 · Reply
ZacksResearch
ZacksResearch Aug. 12 at 12:37 PM
$PODD beats on both top and bottom lines — and the market loves it. Q2 earnings and revenues came in ahead of estimates, with margins moving higher and shares already reacting to the upside. Full breakdown of the bullish setup here 👉 https://www.zacks.com/stock/news/2701834/insulet-q2-earnings-revenues-beat-estimates-stock-up-margins-rise?cid=sm-stocktwits-2-2701834-teaser-7311&ADID=SYND_STOCKTWITS_TWEET_2_2701834_TEASER_7311
0 · Reply
jheerdink
jheerdink Aug. 8 at 7:09 PM
$MODD "The ADCES conference is an ideal location for us to showcase our next-generation patch pump, branded as Pivot, for which we plan to file for U.S. Food and Drug Administration ("FDA") clearance in October 2025. Diabetes care and education specialists are crucial in offering and prescribing pumps to achieve improved clinical outcomes, and we believe they will appreciate the user-friendly design of the Pivot pump and our focus on making diabetes care simpler to learn and manage for our targeted audience of Almost Pumpers," stated Jeb Besser, CEO of Modular Medical. $PODD https://finance.yahoo.com/news/modular-medical-announces-next-generation-120000698.html
1 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 6:04 PM
RBC Capital has adjusted their stance on Insulet ( $PODD ), setting the rating to Outperform with a target price of 330 → 350.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 3:08 PM
Wells Fargo has adjusted their stance on Insulet ( $PODD ), setting the rating to Overweight with a target price of 330 → 350.
0 · Reply
IN0V8
IN0V8 Aug. 8 at 2:22 PM
$PODD Buy Bernstein raises target price to $400 from $375 BTIG raises target price to $370 from $350 Jefferies raises target price to $375 from $360 Morgan Stanley raises target price to $370.00 from $355.00 Wells Fargo raises target price to $350 from $330
0 · Reply
schaeffers
schaeffers Aug. 7 at 8:50 PM
Today's Top 5 Winners: 💚 $PODD 💚 $BDX 💚 $ZBH 💚 $APA 💚 $VTRS
0 · Reply
BriOnH
BriOnH Aug. 7 at 5:54 PM
$PODD Nice!!! Great beats! Healthcare sector getting ripped up though. Is this the first time they have had the ER before the bell? As I recall it's always been after market close.
1 · Reply
jheerdink
jheerdink Aug. 7 at 2:17 PM
$PODD Insulet beats second-quarter profit estimates on strong demand for insulin pumps $MODD $MDT https://finance.yahoo.com/news/insulet-beats-second-quarter-profit-123941614.html
0 · Reply